Pharming Group Nv Stock Buy Hold or Sell Recommendation
| PHGUF Stock | USD 0.75 0.07 8.54% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Pharming Group NV is 'Strong Sell'. Macroaxis provides Pharming Group buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PHGUF positions.
Check out Pharming Group Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Pharming and provide practical buy, sell, or hold advice based on investors' constraints. Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Pharming |
Execute Pharming Group Buy or Sell Advice
The Pharming recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pharming Group NV. Macroaxis does not own or have any residual interests in Pharming Group NV or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharming Group's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Pharming Group Trading Alerts and Improvement Suggestions
| Pharming Group NV generated a negative expected return over the last 90 days | |
| Pharming Group NV has some characteristics of a very speculative penny stock |
Pharming Group Returns Distribution Density
The distribution of Pharming Group's historical returns is an attempt to chart the uncertainty of Pharming Group's future price movements. The chart of the probability distribution of Pharming Group daily returns describes the distribution of returns around its average expected value. We use Pharming Group NV price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pharming Group returns is essential to provide solid investment advice for Pharming Group.
| Mean Return | -0.13 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 2.28 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pharming Group historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pharming Group Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharming Group or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharming Group's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharming pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | -0.09 | |
σ | Overall volatility | 2.31 | |
Ir | Information ratio | -0.11 |
Pharming Group Volatility Alert
Pharming Group NV exhibits very low volatility with skewness of 1.45 and kurtosis of 22.7. Pharming Group NV is a potential penny stock. Although Pharming Group may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Pharming Group NV. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pharming instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Pharming Group Fundamentals Vs Peers
Comparing Pharming Group's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pharming Group's direct or indirect competition across all of the common fundamentals between Pharming Group and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pharming Group or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Pharming Group's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pharming Group by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pharming Group to competition |
| Fundamentals | Pharming Group | Peer Average |
| Return On Equity | 0.17 | -0.31 |
| Return On Asset | 0.0643 | -0.14 |
| Profit Margin | 0.15 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 721.19 M | 16.62 B |
| Shares Outstanding | 652.41 M | 571.82 M |
| Shares Owned By Insiders | 1.97 % | 10.09 % |
| Shares Owned By Institutions | 16.43 % | 39.21 % |
| Price To Earning | 18.97 X | 28.72 X |
| Price To Book | 3.94 X | 9.51 X |
| Price To Sales | 3.69 X | 11.42 X |
| Revenue | 167.68 M | 9.43 B |
| Gross Profit | 177.73 M | 27.38 B |
| EBITDA | 41.22 M | 3.9 B |
| Net Income | 16 M | 570.98 M |
| Cash And Equivalents | 189.96 M | 2.7 B |
| Cash Per Share | 0.29 X | 5.01 X |
| Total Debt | 122.65 M | 5.32 B |
| Debt To Equity | 0.75 % | 48.70 % |
| Current Ratio | 5.22 X | 2.16 X |
| Book Value Per Share | 0.30 X | 1.93 K |
| Cash Flow From Operations | 37.84 M | 971.22 M |
| Earnings Per Share | 0.05 X | 3.12 X |
| Target Price | 24.89 | |
| Number Of Employees | 277 | 18.84 K |
| Beta | 0.98 | -0.15 |
| Market Capitalization | 880.76 M | 19.03 B |
| Total Asset | 350.55 M | 29.47 B |
| Retained Earnings | (273 M) | 9.33 B |
| Working Capital | 23 M | 1.48 B |
| Current Asset | 41 M | 9.34 B |
| Current Liabilities | 18 M | 7.9 B |
| Z Score | 4.2 | 8.72 |
Pharming Group Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pharming . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.75 | |||
| Day Typical Price | 0.75 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) |
About Pharming Group Buy or Sell Advice
When is the right time to buy or sell Pharming Group NV? Buying financial instruments such as Pharming Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pharming Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Developed Markets Basket ETFs Thematic Idea Now
Developed Markets Basket ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Developed Markets Basket ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Developed Markets Basket ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Pharming Pink Sheet
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Pink Sheet, refer to the following important reports:Check out Pharming Group Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.